Feb 2, 2017

Corporate America is obsessed with Trump

Associated Press

Winter earnings season has revealed how many American executives have Trump on the brain. The Wall Street Journal reports that "of the 242 companies in the S&P 500 index that held conference calls or other investor events in January, half mentioned Mr. Trump directly or indirectly."

Why it matters: Donald Trump's big plans for tax, trade and infrastructure affect nearly every American business model. Trump's penchant for calling out, and cutting deals, with individual companies has gotten Corporate America's attention, too.

Irony alert: After the Republican Party spent years criticizing crony capitalism, a Republican President has made good relations with the White House a business must.

Go deeper

Axios

17 mins ago - Politics & Policy

Remembering George Floyd

Photo: Kerem Yucel/AFP via Getty Images

With politicians, clergy and law enforcement in attendance on Thursday in Minneapolis, the family of George Floyd demanded recognition for his life well lived.

Why it matters: Floyd has become the latest symbol of police brutality after he was killed last week when a police officer held a knee to his neck.

Go deeper (1 min. read)

Fadel Allassan

1 hour ago - Politics & Policy

Al Sharpton says Floyd family will lead march on Washington in August

The family of George Floyd is teaming up with the Rev. Al Sharpton to hold a march on Washington on Aug. 28 — the 57th anniversary of the civil rights movement's March on Washington — to call for a federal policing equality act, Sharpton announced during a eulogy at Floyd's memorial service in Minneapolis Thursday.

Why it matters: The news comes amid growing momentum for calls to address systemic racism in policing and other facets of society, after more than a week of protests and social unrest following the killing of Floyd by a Minneapolis police officer.

Go deeper (1 min. read)

Ursula Perano

2 hours ago - Health

Medical journal retracts study that fueled hydroxychloroquine concerns

Photo: George Frey/AFP via Getty Images

The Lancet medical journal retracted a study on Thursday that found that coronavirus patients who took hydroxychloroquine had a higher mortality rate and increased heart problem than those who did nothing, stating that the authors were "unable to complete an independent audit of the data underpinning their analysis."

Why it matters: The results of the study, which claimed to have analyzed data from nearly 96,000 patients on six continents, led several governments to ban the use of the anti-malarial drug for coronavirus patients due to safety concerns.

Go deeper (1 min. read)